EE280 Cost-Effectiveness of TEVAR With Active Control in Patients With TAA and TBAD: A Japanese Public Healthcare Payer Perspective
2025 · Value in Health · 0 citations
https://doi.org/10.1016/j.jval.2025.09.664
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
17
Papers
16
Citations
2
h-index
0
i10-index
Keita Mori is an academic researcher from W. L. Gore & Associates (Germany). The author has contributed to research in topics: Organic Electronics and Photovoltaics & Conducting polymers and applications & Legal and Regulatory Analysis. The author has an h-index of 2, co-authored 15 publications.
Click to start Chat